Trials / Terminated
TerminatedNCT02215148
Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (actual)
- Sponsor
- University of North Carolina, Chapel Hill · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the pharmacokinetic profile of tolvaptan in critically ill acute brain injury patients and to secondarily evaluate the clinical response and safety of tolvaptan in acute brain injured patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tolvaptan |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2014-08-13
- Last updated
- 2016-09-08
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02215148. Inclusion in this directory is not an endorsement.